Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
11 NC counties and 1 VA county are under alert, including Mecklenburg, VA and Northampton counties.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Opiant Pharmaceuticals Inc
(NQ:
OPNT
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Mar 1, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Opiant Pharmaceuticals Inc
< Previous
1
2
3
Next >
Indivior Acquires Opiant Pharmaceuticals Strengthening Its Addiction Treatment And Science Portfolio
March 03, 2023
Indivior PLC (OTCPK:INVVY) (LSE:INDV) has completed the acquisition of Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) The transaction strengthens Indivior's addiction treatment and science portfolio by...
Via
Benzinga
Opiant Pharmaceuticals Announces CFIUS Approval for Proposed Acquisition by Indivior PLC
February 07, 2023
From
Opiant Pharmaceuticals, Inc.
Via
GlobeNewswire
Opiant Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition by Indivior PLC
February 06, 2023
From
Opiant Pharmaceuticals, Inc.
Via
GlobeNewswire
Opiant Pharmaceuticals Announces FDA Acceptance and Priority Review of NDA for OPNT003, Nasal Nalmefene, for Opioid Overdose
January 19, 2023
From
Opiant Pharmaceuticals, Inc.
Via
GlobeNewswire
OPIANT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Opiant Pharmaceuticals, Inc. - OPNT
January 06, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Analyzing Opiant Pharma's Short Interest
January 03, 2023
Opiant Pharma's (NASDAQ:OPNT) short percent of float has risen 148.0% since its last report. The company recently reported that it has 30 thousand shares sold short, which is 0.62% of all regular...
Via
Benzinga
How Is The Market Feeling About Opiant Pharma?
December 08, 2022
Opiant Pharma's (NASDAQ:OPNT) short percent of float has risen 13.79% since its last report. The company recently reported that it has 16 thousand shares sold short, which is 0.33% of all regular...
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Apollo Endosurgery, Inc. (Nasdaq - APEN), Imago BioSciences, Inc. (Nasdaq - IMGO), Opiant Pharmaceuticals Inc. (Nasdaq - OPNT), Benefitfocus, Inc. (Nasdaq - BNFT)
December 05, 2022
From
Brodsky & Smith LLC
Via
GlobeNewswire
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
November 15, 2022
Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus...
Via
Benzinga
Tesla, Amazon, Opiant, Nu, Paramount: Lawsuit, Earnings, Warren Buffett's Increased Stake Draw Investor Attention
November 14, 2022
Major Wall Street indices closed in the red on Monday, in a reversal of last week’s rally driven by softer inflation data.
Via
Benzinga
OPIANT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Opiant Pharmaceuticals, Inc. - OPNT
November 14, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
Looking Into Opiant Pharma's Recent Short Interest
November 14, 2022
Opiant Pharma's (NASDAQ:OPNT) short percent of float has fallen 27.5% since its last report. The company recently reported that it has 14 thousand shares sold short, which is 0.29% of all regular...
Via
Benzinga
Dow Surges 150 Points; Crude Oil Falls Sharply
November 14, 2022
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Monday.
Via
Benzinga
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
November 14, 2022
Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 14, 2022
Gainers
Via
Benzinga
Opiant Pharmaceuticals (NASDAQ: OPNT) Enters Into Definitive Agreement to be Acquired by Indivior for $145 Million
November 14, 2022
Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) is engaged as a specialty pharmaceutical company, which is focused on developing treatments for drug
Via
Spotlight Growth
Stocks Cool Off From Last Week's Rally
November 14, 2022
Stocks are starting the week off lower, unable to build off of last week's impressive rally.
Via
Talk Markets
Silver Rises Over 1%; Tyson Foods Posts Downbeat Earnings
November 14, 2022
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite dropping around 60 points on Monday.
Via
Benzinga
Party City Layoffs 2022: What to Know About the PRTY Job Cuts
November 14, 2022
Party City (PRTY) is the latest company to announce layoffs as it prepares to cut 19% of its workforce due to rising inflation.
Via
InvestorPlace
Why Is Opiant Pharma (OPNT) Stock Up 116% Today?
November 14, 2022
Opiant Pharmaceuticals (OPNT) stock is rocketing higher on Monday following news that Indivior is acquiring the Narcan maker!
Via
InvestorPlace
US Stocks Mostly Lower; Nasdaq Drops Over 100 Points
November 14, 2022
U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping more than 100 points on Monday.
Via
Benzinga
OPNT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Opiant Pharmaceuticals, Inc. Is Fair to Shareholders
November 14, 2022
From
Halper Sadeh LLC
Via
Business Wire
Facebook Stalls Portal & Smartwatch Projects, Visa Breaks Debit Card Tie Up With FTX, $3B Bitcoin Withdrawn From Crypto Exchanges: Top Stories Monday, Nov. 14
November 14, 2022
Reuters
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 14, 2022
Gainers Opiant Pharma (NASDAQ:OPNT) stock rose 118.3% to $20.74 during Monday's pre-market session. The market value of their outstanding shares is at $107.1 million. As per the press release, Q3...
Via
Benzinga
Indivior To Pay Over 100% Premium To Buy Opioid Focused Player Opiant Pharmaceuticals
November 14, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
November 14, 2022
Welcome back and get ready for the week with a breakdown of the biggest pre-market stock movers worth knowing about on Monday morning!
Via
InvestorPlace
Why MorphoSys Shares Are Trading Lower By Around 32%; Here Are 30 Stocks Moving Premarket
November 14, 2022
Via
Benzinga
Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket
September 27, 2022
Gainers 9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 31.4% to $0.2720 in pre-market trading after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA for...
Via
Benzinga
Earnings Scheduled For November 14, 2022
November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Via
Benzinga
MindMed: Financial And Business Results For Q2 2022, Management And Pipeline Changes
August 12, 2022
MindMed (NASDAQ: MNMD), which recently received a letter on behalf of one of its shareholders calling for a new business strategy and offer
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.